Skip to Main Content

Office of Academic & Professional Development

About OAPD

Through programs that offer mentoring and leadership development, our goal is to provide resources to support all faculty in the School of Medicine from the beginning of their Yale careers through their transition to senior faculty leaders. The Office oversees faculty development programs in all departments, and provides regular consultation to faculty as they progress through the academic life-cycle.

Academic & Professional Development Leadership

  • Deputy Dean for Academic Affairs

    Professor of Psychiatry; Deputy Dean for Academic Affairs, OAPD

    I am involved in the coordination of faculty development both within the Department of Psychiatry and in Yale School of Medicine with a focus of working with non-procedural and bridge departments. I have served in several research, education, and clinical leadership positions in the Department of Psychiatry and affiliated non-profit clinical, research, and policy organizations including The APT Foundation, Silver Hill Hospital, and The National Center of Addiction and Substance Abuse. I direct the faculty reappointment and promotion processes in my department and am involved in the development and evaluation of medical school-wide junior faculty mentoring programs. I am a trained mentor and professional coach and consult with junior faculty and departmental leaders on: promotion processes and readiness; incorporation into academic review processes improved assessments of clinical and educational excellence, professionalism, and diversity and inclusion activities, and; consultation on matters related to professional stress, burnout, and impairment. My clinical expertise is the treatment of patients with addiction and co-occurring personality disorders, and I have developed and conducted clinical trials on a specialized psychotherapy for these complex patients and founded a specialized residential treatment program for high functioning professionals (particularly physicians and attorneys) and executives suffering from these disorders. During the COVID-19 pandemic, I  developed and directed a 1:1 professional support provider services program for Yale  Medicine and Yale New Haven Health healthcare workers and their families.
  • Deputy Dean for Professionalism and Leadership

    Professor of Psychiatry, Deputy Dean for Professionalism and Leadership; Associate Dean for Global Health Education, Affiliated Faculty, Yale Institute for Global Health; Affiliated Faculty, Yale Institute for Global Health

    A graduate of Franklin and Marshall College, Yale School of Medicine and the Yale Psychiatry residency and geriatric psychiatry fellowship programs, Throughout his career Dr. Rohrbaugh has been active in developing clinical programs that integrate medical student and residency education. He has been especially interested in teaching beginning clinicians how to listen to a patient's narrative, identify pertinent data, and use that data to develop a bio-psycho-social formulation and treatment plan. Dr. Rohrbaugh developed the VA-CT Psychiatry Primary Care Clinic and Geropsychiatry service and served as Clinical Director of VA-CT Mental Health Service Line. He served as the Clerkship Director and Director of Medical Studies for medical student education and as Associate Program Director before leaving the VA to assume the Program Director role in 2008. In 2009, Dr. Rohrbaugh was named Deputy Chair for Education and Career Development in the Department of Psychiatry. In his residency program director role, Dr. Rohrbaugh facilitated the development of a social justice and health equity track within the residency to equip psychiatrists to address health disparities as part of their clinical mission. Dr. Rohrbaugh has worked with colleagues at Xiangya School of Medicine in Changsha, Hunan Province, PRC to develop a competency based model for post-graduate (residency) education. This model has heavily influenced the Chinese national model for residency training. He was the Founding Director of the Yale School of Medicine's Office of International Medical Student Education in 2008 and was named Associate Dean for Global Health Education. In 2015, having noted the irony that global health education is largely discussed by educators in high income countries, Dr. Rohrbaugh co-founded the Bellagio Global Health Education Initiative with an explicit goal of bringing global health education leaders from high, middle and low income countries together to improve global health education. In 2021 Dr. Rohrbaugh became Deputy Dean for Professionalism and Leadership at Yale School of Medicine. In this role he leads a team whose mission is to improve the culture of the School by promoting professionalism, developing faculty leaders, and elevating well-being of faculty.
  • Associate Dean for Faculty Affairs

    Professor of Orthopaedics & Rehabilitation; Associate Dean, Faculty Affairs; Director of Orthopaedic Spine Service, Orthopaedics & Rehabilitation; Associate Vice-Chair Research, Orthopaedics & Rehabilitation

    Dr. Grauer is a professor at Yale School of Medicine. He received his Bachelor of Science degree from Tufts University, graduating summa cum laude and with Phi Beta Kappa. He received his Medical Doctorate from Yale School of Medicine, graduating cum laude and with Alpha Omega Alpha. He completed his Orthopaedic Surgery residency at Yale New Haven Hospital and a fellowship in spine surgery at the Rothman Institute at Thomas Jefferson University. Clinically, Dr. Grauer is a spine surgeon and Director of the Orthopaedic Spine Service for the Yale Department of Orthopaedics and Rehabilitation. He specializes in the treatment of numerous conditions affecting the cervical, thoracic, and lumbosacral spine including degenerative conditions, scoliosis, trauma, infections, and tumors. His clinical practice is based out of Yale New Haven Hospital, and outpatients are seen at the Yale New Haven Hospital Spine Center. Academically, Dr. Grauer is active with clinical outcomes research and is an Associate Vice-Chair of Research for the Yale Department of Orthopaedics and Rehabilitation. Nationally, he is active with many societies and editor-in-chief of the North American Spine Society Journal (NASSJ). Administratively, Dr Grauer is Associate Dean of Faculty Affairs for Yale School of Medicine. He is a point of contact for departments with the Office of Academic and Professional Development (OAPD) and responsible for a number of related projects related to that office.

OAPD Staff

  • OAPD: Faculty Affairs Staff

  • OAPD: Professionalism and Leadership Team

    • Deputy Dean for Professionalism and Leadership

      Professor of Psychiatry, Deputy Dean for Professionalism and Leadership; Associate Dean for Global Health Education, Affiliated Faculty, Yale Institute for Global Health; Affiliated Faculty, Yale Institute for Global Health

      A graduate of Franklin and Marshall College, Yale School of Medicine and the Yale Psychiatry residency and geriatric psychiatry fellowship programs, Throughout his career Dr. Rohrbaugh has been active in developing clinical programs that integrate medical student and residency education. He has been especially interested in teaching beginning clinicians how to listen to a patient's narrative, identify pertinent data, and use that data to develop a bio-psycho-social formulation and treatment plan. Dr. Rohrbaugh developed the VA-CT Psychiatry Primary Care Clinic and Geropsychiatry service and served as Clinical Director of VA-CT Mental Health Service Line. He served as the Clerkship Director and Director of Medical Studies for medical student education and as Associate Program Director before leaving the VA to assume the Program Director role in 2008. In 2009, Dr. Rohrbaugh was named Deputy Chair for Education and Career Development in the Department of Psychiatry. In his residency program director role, Dr. Rohrbaugh facilitated the development of a social justice and health equity track within the residency to equip psychiatrists to address health disparities as part of their clinical mission. Dr. Rohrbaugh has worked with colleagues at Xiangya School of Medicine in Changsha, Hunan Province, PRC to develop a competency based model for post-graduate (residency) education. This model has heavily influenced the Chinese national model for residency training. He was the Founding Director of the Yale School of Medicine's Office of International Medical Student Education in 2008 and was named Associate Dean for Global Health Education. In 2015, having noted the irony that global health education is largely discussed by educators in high income countries, Dr. Rohrbaugh co-founded the Bellagio Global Health Education Initiative with an explicit goal of bringing global health education leaders from high, middle and low income countries together to improve global health education. In 2021 Dr. Rohrbaugh became Deputy Dean for Professionalism and Leadership at Yale School of Medicine. In this role he leads a team whose mission is to improve the culture of the School by promoting professionalism, developing faculty leaders, and elevating well-being of faculty.
    • Senior Director of Professionalism and Leadership

      Sr. Director, Professionalism and Leadership, YSM Office of Academic Professionalism and Development

      Andrea Terrillion, JD is the Director of Professionalism and Leadership Development in the Office of Academic and Professional Development (OAPD).  Ms. Terrillion partners with Deputy Dean for Professionalism and Leadership, Robert Rohrbaugh, MD to formulate the overarching principles and activities of OAPD related to professionalism and leadership, including enhanced interventions to strengthen professionalism and the design of value-based leadership development programs.   Ms. Terrillion has held various roles at Yale including director of employee relations and director of labor relations. She continues to play a role in investigating complex, high level and highly confidential matters across campus and supporting Employee Relations through her leadership and training efforts. Prior to joining Yale, Ms. Terrillion had extensive labor and employee relations consulting experience and practiced for many years as a labor and employment attorney.  In addition, she served as director of legal and labor relations education and consultation programming at the Outreach Division of Cornell University’s ILR School and has been a member of the adjunct faculty, as well.  Ms. Terrillion has lectured throughout the United States on various workplace law and employee relations issues and provided legal commentary for print, radio and television media.
    • Assistant Professor in the Child Study Center; Director for Leadership Development and Coaching Initiatives, Offices of Academic & Professional Development (OAPD) and Diversity, Equity, and Inclusion (ODEI)

      Daryn H. David, PhD, is a licensed clinical psychologist, educator, and leadership development coach. At the Yale School of Medicine, Daryn is an Assistant Professor at the Child Study Center and serves as Director for Leadership Development and Coaching Initiatives in the Offices of Academic & Professional Development (OAPD) and Diversity, Equity, & Inclusion (ODEI). Through dynamic pedagogy, leadership development coaching, and innovative programming, Daryn leverages her expertise to help academics and health care providers actualize their fullest professional potential. She further promotes the educational mission of Yale University by coaching high-impact global leaders through the Yale Greenberg World Fellowship. In addition to her work in academia, Daryn maintains a small psychotherapy and coaching practice devoted to supporting women professionals. Daryn holds a Bachelor of Arts (AB) degree in Social Studies from Harvard University and a PhD in psychology from Yale University, where she also completed her predoctoral clinical internship and postdoctoral fellowship. Following her formal academic training, Daryn pursued an American Association for the Advancement of Science (AAAS) Science & Technology Policy fellowship at the National Institutes of Health. Additionally, she completed the Playing Big Facilitators Training with Tara Mohr and the Blue Mesa Transformational Coaching Program and is a certified facilitator of the Zenger Folkman Extraordinary Leader, Advancing the Extraordinary Leader, and Extraordinary Performer workshops.
    • Program Manager, OAPD

      Kezia Dos Santos is the Project and Program Administrator for the Office of Academic and Professional Development. Kezia is responsible for leading special projects, programs, and initiatives that promote faculty professionalism, leadership development, and the well-being of YSM’s faculty. As a process improvement enthusiast, creative and analytical thinker, and an intuitive problem-solver, Kezia supports the Deputy Dean for Professionalism and Leadership, Robert Rohrbaugh, MD, and the Director for Professionalism and Leadership Development, Andrea Terrillion, JD. Kezia holds a Bachelor of Arts degree in psychology from the University of Connecticut and a Master of Science degree in strategic human resources management from Sacred Heart University. The integration of Kezia’s passions between psychology and people management was the perfect combination and launching pad to set her on the path to help improve the quality of life of those she interacts with both professionally and personally. Kezia joined Yale in 2015 as a Sr. Administrative Assistant for the Sterling Memorial Library, Employee Relations Support Specialist for YSM and Yale Human Resources, and Assistant Administrator for the departments of Microbial Pathogenesis and Cellular and Molecular Physiology, where she discovered that she enjoyed working with Faculty. Prior to joining Yale, Kezia had progressive experience in different industries in the private sector as an Executive Assistant and Office Manager.
    • Sr Assoc. Director Professionalism & Leadership

      Karen Wu, JD is the Senior Associate Director of Professionalism and Leadership Development in YSM’s Office of Academic and Professional Development (OAPD). Ms. Wu partners with OAPD Deputy Dean for Professionalism and Leadership, Robert Rohrbaugh, MD, and Senior Director for Professionalism and Leadership Development, Andrea Terrillion, JD, to develop and implement programs and initiatives focused on enhancing faculty professionalism, leadership development and well-being. Ms. Wu has held previous human resources roles at Yale, including director of employee relations for the central academic units, where she advised academic and administrative leaders in the Office of the Provost, Faculty of Arts and Sciences, Yale College, and professional schools on a variety of strategic workforce planning and operational issues. Prior to joining Yale, Ms. Wu served as an employee relations advisor and human resources business partner, advising leaders and employees in a variety of industries, including financial services and media. She also brings extensive experience as a labor and employment attorney to her current role at Yale.
  • Senior Appointments & Promotions Committee

    • Committee Chair

      Jean and David W. Wallace Dean of the Yale School of Medicine and C.N.H. Long Professor of Internal Medicine

      Nancy J. Brown, M.D. is the Jean and David W. Wallace Dean of Yale School of Medicine and the C.N.H. Long professor of Internal Medicine. Prior to coming to Yale, Dr. Brown served as chair of the Vanderbilt Department of Medicine and physician-in-chief of Vanderbilt University Medical Center from 2010 to 2020. Dr. Brown's research has focused on the mechanisms through which the renin-angiotensin-aldosterone, kallikrein-kinin, and incretin systems affect inflammation, thrombosis, metabolism and cardiovascular risk. Her lab defined the contribution of endogenous bradykinin to fibrinolysis and the prothrombotic and fibrotic effects of aldosterone mediated by plasminogen activator inhibitor-1. Her research group identified African ancestry and specific genetic variants as risk factors for angiotensin-converting enzyme (ACE) inhibitor-associated angioedema. Ongoing research in the laboratory focuses on the mechanism(s) of combined angiotensin receptor blocker (ARB)/neprilysin inhibitors in heart failure as well as on the cardiovascular effects of incretin-based anti-diabetic therapies. As a clinician, Dr. Brown's specializes in the diagnosis and treatment of resistant hypertension; since coming to Yale, she has volunteered in the HAVEN clinic. Throughout her career, Dr. Brown has worked to promote the development of physician-scientists. She established the Vanderbilt Master of Science in Clinical Investigation in 2000. From 2006-2010, she served as the Associate Dean for Clinical and Translational Scientist Development and established an institutional infrastructure to support physician-scientists in the transition to independence. Dr. Brown served on the NIH National Advisory Research Resources Council and the National Heart, Lung, and Blood Advisory Council. Her research has been recognized by the Harriet Dustan Award from the American Heart Association, the E.K. Frey-E. Werle Foundation, the August M. Watanabe Prize in Translational Research, and others. In 2018, she was named the Robert H. Williams, MD, Distinguished Chair of Medicine by the Association of Professors of Medicine. Dr. Brown is a fellow in the American Association for the Advancement of Science and a member of the American Society for Clinical Investigation, the American Association of Physicians, the American Clinical and Climatological Association, the National Academy of Medicine, and the American Academy of Arts and Sciences.
    • Committee Co-Chair

      Harold W. Jockers Professor of Medicine, Deputy Dean for Academic Affairs

      Dr. Linda Bockenstedt is the Harold W. Jockers Professor of Medicine, Section of Rheumatology, and Deputy Dean for Faculty Affairs at Yale School of Medicine. She received her undergraduate degree in chemistry and physics from Harvard College and is a graduate of the Ohio State University School of Medicine. After completing residency training in medicine and serving as Chief Resident in Medicine at Yale, Dr. Bockenstedt obtained rheumatology clinical and research fellowship training at the University of California, San Francisco. She has been a faculty member at Yale School of Medicine since 1989, where she directs a research program devoted toward understanding the pathogenesis of Lyme disease, an infection-related rheumatic disease. Her research has been continually supported by the National Institutes of Health since 1990, and she is internationally recognized for her studies of the host immune response to spirochetal infection. As a physician-scientist, she also is an active clinician and educator for medical trainees. Dr. Bockenstedt is a Master of the American College of Rheumatology, and an elected member of the Kunkel Society and the Interurban Clinical Club. She is a former standing member of the Immunity and Host Defense Study Section at NIH and former member of the Board of Directors for the American College of Rheumatology Research & Education Foundation. She currently serves on the NIH NIAID Council and the DOD Tick-Borne Disease Research Program Programmatic Panel. Since 2006 she has been active in faculty affairs at Yale School of Medicine and in 2017, was appointed YSM Deputy Dean for Academic Affairs.
    • Term January 2022-December 2024

      Rothberg Professor of Neurosurgery; Vice Chair of Research, Neurosurgery, Neurosurgery

      Dr. Angélique Bordey holds the rank of Professor of Neurosurgery, and Cellular & Molecular Physiology. Dr. Bordey is an active participant in teaching and training of graduate and medical students at Yale School of Medicine. Dr. Bordey is an  Editor for several journals and on the advisory board of CURE epilepsy and the TSC Alliance preclinical consortium. She has served as a permanent member on several grant review committees and NIH study sections. Finally, she is a McKnight awardee and holds several federal and foundation grants as well as patents for the treatment of epilepsy.
    • Term January 2023-December 2025

      Professor of Surgery (Vascular) and of Cellular and Molecular Physiology; Chief of Surgery, VA Connecticut; Principal Investigator, Dardik Laboratory; Editor-in-Chief, JVS-Vascular Science; Affiliated Faculty, Yale Institute for Global Health

      Dr. Alan Dardik is a surgeon-scientist who harnesses the power of molecular biology to achieve a modern understanding of vascular disease, and then use the basic science laboratory to ultimately benefit patients with vascular diseases. Dr. Dardik trained at Yale, the University of Pennsylvania, and the Johns Hopkins Hospital before his appointment to the Yale faculty in 2001. Dr. Dardik focuses his clinical practice on teaching at the VA Connecticut, where he was formerly the Chief of Vascular Surgery and currently serves as the Chief of Surgery. Dr. Dardik has won the C. Elton Cahow Award for Outstanding Faculty Teaching from Yale’s Department of Surgery and the Faculty Teaching Award from St. Mary’s Hospital. Dr. Dardik has served Yale’s Department of Surgery as a Vice Chair of Faculty Affairs, as well as Interim Division Chief of Vascular and Endovascular Surgery. The Dardik laboratory studies the healing and function of blood vessels, fistulae and vessel patches that are used in patients having vascular surgery. The laboratory is trying to understand the fundamental molecular mechanisms by which vein graft adaptation and arteriovenous fistula maturation result in positive remodeling and successful adaptation to the arterial environment, yet often proceed, in the long-term, to neointimal hyperplasia and failure. The laboratory also studies novel methods to deliver stem cells to diabetic wounds. The laboratory is funded from the NIH as well as Yale's Department of Surgery. Dr. Dardik currently serves as the Editor-in-Chief for the translational science journal JVS-Vascular Science; he is the past President of the New England Society for Vascular Surgery, the Association of VA Surgeons as well as of the International Society for Vascular Surgery. Dr. Dardik has run several national and international meetings, including the Society for Vascular Surgery Vascular Research Initiatives Conference, and has served on numerous peer review committees including review for the NIH, the VA, and Vascular Cures. Dr. Dardik has edited several textbooks including “Vascular Surgery: A Global Perspective” and “Stem cell therapy for vascular diseases.”
    • Term January 2022-December 2024

      Professor of Psychiatry; Medical Director Hispanic Clinic and Latino Behavioral Health System; Associate Director Psychiatry Residency Program

      Esperanza Díaz M.D. attended Javeriana University in Bogotá, Colombia, and completed Psychiatry residency training at Yale. She graduated from the Western New England Institute for Psychoanalysis. As medical director of the Hispanic Clinic and its expansion to the community, mental health services for Limited English proficiency populations are a model. She founded the Hispanic Psychiatry Fellowship addressing mental health disparities in Latinos. Along with residents, she developed the Cultural Psychiatry curriculum, a predecessor of the Social Justice and Health Equity curriculum. Her work with the medical school Teaching and Learning Center addresses cultural sensitivity and microaggressions management training. Using an experiential model, she leads interviewing training for residents. She chairs the evaluation committee to review and revise the Yale Psychiatry evaluation system.
    • Term January 2024-December 2026

      Wayne O. Southwick Professor of Orthopaedics and Rehabilitation and Professor of Pathology; Chair Emeritus, Department of Orthopaedics and Rehabilitation

      Dr. Friedlaender received his BA and MD degrees from the University of Michigan and his orthopaedic surgical training at Yale-New Haven Hospital and Newington Children’s Hospital. In 1976, after 2 years service in the U.S. Navy assigned to the Naval Medical Research Institute in Bethesda, Dr. Friedlaender joined the full-time faculty of Yale University School of Medicine and since 1986 has served as the Wayne O. Southwick Professor and, until 2016, Chair of the Department of Orthopaedics and Rehabilitation and Chief of Orthopaedics and Rehabilitation at Yale New Haven Hospital. Dr. Friedlaender has also trained at Massachusetts General Hospital in musculoskeletal oncology, which remains his primary clinical and research interest.Learn more about Dr. Friedlaender>>Dr. Friedlaender has served as President of the American Association of Tissue Banks (1983-85), the American Council on Transplantation (1983-85), the Orthopaedic Research Society (1994-95), the Academic Orthopaedic Society (1995-96), the Association of Bone and Joint Surgeons (2001-02) and the American Orthopaedic Association (2010-11). He has also chaired the American Academy of Orthopaedic Surgeon’s Council of Musculoskeletal Specialty Societies and served as a member of the Academy’s Board of Directors and as a member of the AAOS Committee on Ethics. In the past, Dr. Friedlaender served as Chair of the National Arthritis Board, NIAMS (NIH), as a member of the Orthopaedic Study Section at NIH and as a member of the Advisory Council of NIAMS. He was chair of the Research Committees of the American Academy of Orthopaedic Surgeons and the Academic Orthopaedic Society and chaired the AAOS work group on Tissue Banking Issues. He served or serves on the editorial boards of several journals, including the Journal of Bone and Joint Surgery, Clinical Orthopaedics and Related Research, Spine, Journal of Orthopaedic Research and the Journal of the American Academy of Orthopaedic Surgeons; and he has written numerous scientific publications and received national awards for his basic science research (Kappa Delta Award of the American Academy of Orthopaedic Surgery and the Nicholas Andry Award of the Association of Bone and Joint Surgeons).
    • Term January 2024-December 2026

      Professor of Surgery (Oncology, Breast); Executive Vice Chair, Surgery; Deputy Chief Medical Officer for Surgical Services, Smilow Cancer Hospital

      Mehra Golshan, MD, MBA, is a cancer surgeon and a nationally and internationally recognized leader in breast cancer treatment and research. In addition to caring for patients, he serves as Deputy Chief Medical Officer for Surgical Services at Smilow Cancer Hospital and Yale Cancer Center. Dr. Golshan also serves as the Executive Vice Chair of Operations in the Department of Surgery and Professor of Surgical Oncology at the Yale School of Medicine. Dr. Golshan is a leader in the research with over 150 peer reviewed publications. He has led numerous Phase I, II and III clinical trials and translational science innovations impacting the treatment options and outcomes for women. He is an innovator in tailoring surgery and therapy for women with early stage breast cancer with funding support from the Breast Cancer Research Foundation and National Institutes of Health. He is the principal investigator of several phase II trials aiming to reduce the need for second surgeries or re-excisions in women with breast cancer, one of which uses innovative image-guided operating room capabilities to capture and remove all residual tumor utilizing MRI and mass spectrometry which is used at Yale’s hybrid operating room. Dr. Golshan prides himself on being an educator having trained and mentored over a hundred breast surgical fellows as well as international surgeons. He has lectured and taught surgeons, trainees and students nationally and internationally in the field of oncology and breast cancer treatment. Dr. Golshan is a Board Member of the National Accreditation Program for Breast Centers (NAPBC), Chair of NAPBC Education Committee, Chair of the American College of Surgeons Committee on Interprofessional Education and Practice, and Chair of the American Society of Breast Surgeons Question of the Week Committee. Dr. Golshan completed his fellowship in breast surgical oncology at Northwestern Memorial Hospital. He earned his Medical Degree from Case Western Reserve University School of Medicine and an MBA at Massachusetts Institute of Technology, Sloan School of Management in Cambridge Massachusetts. Prior to joining Yale, he spent 17 years in Boston at Harvard’s Brigham and Women’s Hospital, Dana Farber Cancer Institute where he was the inaugural and incumbent Dr. Abdul Mohsen and Sultana Al-Tuwaijri Distinguished Chair in Surgical Oncology. He also served as the Director of the Breast Surgical Oncology Fellowship at the Dana-Farber Cancer Institute/Brigham and Women’s Hospital/Massachusetts General Hospital and was an Associate Professor of Surgery at Harvard Medical School. Dr. Golshan’s approach to breast cancer treatment is through a specialized team approach. For each new patient, Smilow brings together a team of medical oncologists, radiation oncologists, reconstruction surgeons, pathologists, genetics, breast imagers, radiologists, program nurses, and a robust clinical research program. “I work closely with so many colleagues dedicated deeply to treating and curing breast cancer who inspire me to be a better physician, scientist, and person every day."
    • Term January 2022-December 2025

      Harvey and Kate Cushing Professor of Medicine (Endocrinology) and Professor of Neuroscience

      Elizabeth Jonas received training in Neurology and Internal Medicine. She developed an interest in Neuroscience while studying as a medical student with Dr. Rodolfo Llinas at N.Y.U. and at the Marine Biological Laboratory. With Dr. Llinas she developed an interest in calcium control of synaptic transmission. She pursued this interest as a post-doctoral fellow in the laboratory of Dr. Leonard Kaczmarek, Yale Pharmacology. Dr. Jonas developed a technique for recording from ion channels on intracellular membranes and has used this and other techniques to study mitochondria. Mitochondria are necessary for life and death of neurons and other cells. Regulation of mitochondrial metabolism is also key to energy efficiency in the nervous system. Dr. Jonas is now studying the role of mitochondria and energy efficiency in neurodegenerative disease states and in learning and memory formation in healthy brain. Her lab has recently characterized the molecular identity of the cell death channel known as the mitochondrial permeability transition pore and is now studying how inhibiting gating of the pore may ameliorate stroke, neurodegenerative and developmental brain diseases.
    • Term January 2022-December 2024

      Harris Professor in the Child Study Center; Director, Yale Developmental Disabilities Clinic; Director of Undergraduate Studies, Yale Child Study Center; Co-Director of Team Science, Yale Center for Clinical Investigation (YCCI)

      James C. McPartland, Ph.D., is Professor of Child Psychiatry and Psychology at the Yale Child Study Center. He is a licensed child psychologist and Director of the Yale Developmental Disabilities Clinic. He is Director of Undergraduate Studies at the Child Study Center and teaches an undergraduate seminar on autism spectrum disorder. Dr. McPartland’s program of research investigates the brain bases of neurodevelopmental conditions to develop biologically-based tools to improve detection and treatment. His research has been continuously supported since 2007 by both federal (NIMH, NICHD, NINDS, NIDCD; R21, R03, K23, R01, U19) and private research grants (NARSAD, the Autism Science Foundation, the Waterloo Foundation, Autism Speaks, the Patterson Trust, the Simons Foundation, the Nancy Taylor Foundation, the Alan B. Slifka Foundation, the Hilibrand Foundation). He is the Principal Investigator of the Autism Biomarkers Consortium for Clinical Trials, a US-based effort to identify biomarkers to support intervention research in autism. His contributions to the field have been recognized by multiple awards, including the NARSAD Atherton Young Investigator Award, the International Society for Autism Research Young Investigator Award, the Patterson Trust Clinical Research Award, the Brain & Behavior Research Foundation Klerman Prize, and the APA Sara S. Sparrow Early Career Research Award. He is a Fellow of the American Psychological Association and the Association for Psychological Science and has published 5 books and over 170 scholarly works on autism and related topics. He has served on the executive boards of the International Society for Autism Research and the APA Division of Intellectual and Developmental Disabilities/Autism Spectrum Disorder and is on the editorial boards of the Journal of Neurodevelopmental Disorders, the Journal of Mental Health Research in Intellectual Disabilities, the Journal of Autism and Developmental Disorders, and the Encyclopedia of Autism and Related Disorders.
    • Term January 2024-December 2026

      Nixdorff-German Professor of Neurosurgery; Executive Vice Chair, Neurosurgery; Division Chief, Spine, Neurosurgery; Disease Center Director, Spine Oncology Program, Yale Cancer Center

      Dr. Ehud Mendel joined Yale in September 2021 as a Professor of Neurosurgery. He serves as the Disease Center Director of the Spine Oncology Program and member of the Executive Leadership Group at Smilow Cancer Hospital/ Yale Cancer Center at Yale New Haven Hospital. He also serves as the Division Chief of the Spine section, Neurosurgery, and the Executive Vice Chair in the Department of Neurosurgery at the Yale School of Medicine.Dr. Mendel comes to Yale from Wexner Medical Center at The Ohio State University (OSU) and the James Cancer Hospital Solove Research Institute, where he served as the director of the Spine Oncology Program and clinical director of the Ohio State University Spine Research Institute. While at OSU, Dr. Mendel led a multidisciplinary team that made incredible advances in oncological spine surgery. Among many things, his team pioneered a new surgical technique to reconstruct the spine following surgery to remove spinal tumors and has spent his career developing numerous spine tumors research protocols and spine surgery techniques. A true academic surgeon, Dr. Mendel comes to Yale with a wealth of experience in teaching, research, and clinical affairs. In 2006, he became the first honoree of The Justine Skestos Endowed Chair in Minimally Invasive Neurological Spinal Surgery and was recognized for his excellent contributions to education with the Lawrence Mervis, MD Teacher of the Year award in 2016. In addition to seeing patients, Dr. Mendel also served as vice chair for clinical affairs and was elected by his peers to the OSU University Senate and OSU Faculty Council. An honors graduate from Louisiana State University School of Medicine in New Orleans, Dr. Mendel also holds an MBA from The Ohio State University Max M. Fisher College of Business. He completed his residency at the University of Southern California Medical Center and a fellowship in reconstructive spinal surgery-combined neurosurgery/orthopedics at the University of Florida School of Medicine.From 2017 to 2019, he served as president of the Ohio State Neurosurgical Society. He is a fellow of the American College of Surgeons (FACS) and a fellow of the American Association for the Advancement of Science (AAAS). He is a member of AOA Honor’s Society and was selected for the American Academy of Neurological Surgery.
    • Term January 2023-December 2025

      Professor; Regional Director, Ambulatory Services, Yale Medicine; Director, Pediatric IBD program, Pediatrics

      Dr. Pashankar completed his basic medical training in India and in the UK. He completed fellowship training in Pediatric Gastroenterology at BC Children's Hospital in Vancouver, Canada. He has MBA in healthcare from Yale School of Management and has expertise in process and quality improvement. His clinical and research interest is in inflammatory bowel disease in children. He is the director of Yale Pediatric Inflammatory Bowel Disease Program. He runs a multidisciplinary Inflammatory Bowel disease clinic at Yale New Haven Children's Hospital in New Haven. He has published a number of clinical studies in quality improvement, pediatric gastroenterology and inflammatory bowel diseases. He has presented his work in many national and international conferences. In addition, he has an active administrative role in Yale medicine. As a medical director of Yale Clinical Optimization Service, he evaluated ambulatory operation of pediatric and adult medical and surgical specialties, resulting in improvement in patient workflow, revenue , patient and provider satisfaction. He is a medical director of Yale Medicine ambulatory services and oversees 40 Yale Medicine clinics in Fairfield county, New Haven and shoreline regions.
    • Term January 2022-December 2024

      Elizabeth Mears and House Jameson Professor of Psychiatry; Deputy Chair for Translational Research, Psychiatry; Director, Clinical Neuroscience Research Unit, Psychiatry; Director, Yale Program for Psychedelic Science, Psychiatry; Director, Yale Center for Brain and Mind Health, Yale School of Medicine; Director, Yale OCD Research Clinic, Psychiatry; Director, Neuroscience Research Training Program, Yale Department of Psychiatry

      Chris Pittenger earned his MD and Ph.D. degrees from Columbia University, where his graduate work was done with Nobel Prize recipient Eric Kandel. He returned to Yale University, his undergraduate alma mater, for residency and research training in psychiatry in 2003. He joined the faculty as an Assistant Professor in 2007 and is now Elizabeth Mears and House Jameson Professor of Psychiatry, Professor of Psychology and in the Child Study Center, and Deputy Chair for Translational Research in the Department of Psychiatry .Chris has always been fascinated by the question of how the brain, a complex but ultimately a physical structure, creates thought, feeling, consciousness, and other aspects of the mind.  As a psychiatrist he is additionally focused on how these processes go wrong - how brain dysregulation leads to dysregulated cognition, emotion, and behavior and to mental suffering, and how advancing our understanding of these relationships can guide us to new strategies to alleviate that suffering.  Much of his work has focused on obsessive-compulsive disorder and Tourette syndrome and on the cortico-basal ganglia circuitry that is implicated in their pathophysiology.  More recently he has co-founded the Yale Program for Psychedelic Science, focused on understanding how molecules like psilocybin and LSD can teach us about brain and behavior and may lead to new treatments for a range of neuropsychiatric pathology.  He is also one of the founding Directors of the Yale Center for Brain and Mind Health, which seeks to bridge disciplines and levels of analysis to bring new therapeutics to individuals suffering from disorders of the mind and brain.Dr. Pittenger's research and clinical work have been acknowledged by a number of prestigious awards, including grant funding from the National Institute of Mental Health, the National Institute of Neurological Disease and Stroke, NARSAD, the Tourette Syndrome of America, the Doris Duke Charitable Trust, and other organizations.  He has won a number of awards, including from the National Institute of Mental Health, the Society for Neuroscience, the American College of Neuropsychopharmacology, the American Psychiatric Association, and the American College of Psychiatrists. He is a member of the Scientific Advisory Board of the International OCD Foundation and Chair of both their Grant Review Committee and their Annual Research Symposium Planning Committee.  He is a Fellow of the American College of Neuropsychopharmacology, the American Psychiatric Association, and the American Neurological Association.
  • TACBS Appointments & Promotions Committee

    • Tenure Appointments Committee Co-Chair

      Jean and David W. Wallace Dean of the Yale School of Medicine and C.N.H. Long Professor of Internal Medicine

      Nancy J. Brown, M.D. is the Jean and David W. Wallace Dean of Yale School of Medicine and the C.N.H. Long professor of Internal Medicine. Prior to coming to Yale, Dr. Brown served as chair of the Vanderbilt Department of Medicine and physician-in-chief of Vanderbilt University Medical Center from 2010 to 2020. Dr. Brown's research has focused on the mechanisms through which the renin-angiotensin-aldosterone, kallikrein-kinin, and incretin systems affect inflammation, thrombosis, metabolism and cardiovascular risk. Her lab defined the contribution of endogenous bradykinin to fibrinolysis and the prothrombotic and fibrotic effects of aldosterone mediated by plasminogen activator inhibitor-1. Her research group identified African ancestry and specific genetic variants as risk factors for angiotensin-converting enzyme (ACE) inhibitor-associated angioedema. Ongoing research in the laboratory focuses on the mechanism(s) of combined angiotensin receptor blocker (ARB)/neprilysin inhibitors in heart failure as well as on the cardiovascular effects of incretin-based anti-diabetic therapies. As a clinician, Dr. Brown's specializes in the diagnosis and treatment of resistant hypertension; since coming to Yale, she has volunteered in the HAVEN clinic. Throughout her career, Dr. Brown has worked to promote the development of physician-scientists. She established the Vanderbilt Master of Science in Clinical Investigation in 2000. From 2006-2010, she served as the Associate Dean for Clinical and Translational Scientist Development and established an institutional infrastructure to support physician-scientists in the transition to independence. Dr. Brown served on the NIH National Advisory Research Resources Council and the National Heart, Lung, and Blood Advisory Council. Her research has been recognized by the Harriet Dustan Award from the American Heart Association, the E.K. Frey-E. Werle Foundation, the August M. Watanabe Prize in Translational Research, and others. In 2018, she was named the Robert H. Williams, MD, Distinguished Chair of Medicine by the Association of Professors of Medicine. Dr. Brown is a fellow in the American Association for the Advancement of Science and a member of the American Society for Clinical Investigation, the American Association of Physicians, the American Clinical and Climatological Association, the National Academy of Medicine, and the American Academy of Arts and Sciences.
    • Tenure Appointments Committee Co-Chair

      Dean of the Faculty of Arts and Sciences, Vincent J. Scully Professor of Philosophy and Professor of Psychology and Cognitive Sciences

    • Biological Sciences Area Chair

      Sterling Professor of Molecular, Cellular, and Developmental Biology and Professor of Molecular Biophysics and Biochemistry; Investigator, Howard Hughes Medical Institute, Molecular, Cellular and Developmental Biology; Chair, Dept Basic Science: Molecular Biophysics & Biochemistry

      Dr. Breaker is a Sterling Professor of the Department of Molecular, Cellular and Developmental Biology at Yale University, is jointly appointed as a professor in the Department of Molecular Biophysics and Biochemistry, and is an Investigator with the Howard Hughes Medical Institute. His graduate studies with Dr. Peter Gilham at Purdue University focused on the synthesis of RNA and the catalytic properties of nucleic acids. As a postdoctoral researcher with Dr. Gerald Joyce at The Scripps Research Institute, Dr. Breaker pioneered a variety of in vitro evolution strategies to isolate novel RNA enzymes and was the first to discover catalytic DNAs or “deoxyribozymes” using this technology. Since establishing his laboratory at Yale in 1995, Dr. Breaker has continued to conduct research on the advanced functions of nucleic acids, including ribozyme reaction mechanisms, molecular switch technology, next-generation biosensors, and catalytic DNA engineering. In addition, his laboratory has established the first proofs that metabolites are directly bound by messenger RNA elements called riboswitches. Dr. Breaker’s research findings have been published in more than 220 scientific papers, book chapters, and patent applications, and his research has been funded by grants from the NIH, NSF, DARPA, the Hereditary Disease Foundation, and from several biotechnology and pharmaceutical companies. He is the recipient of fellowships from the Arnold and Mabel Beckman Foundation, the David and Lucile Packard Foundation, and the Hellman Family Trust. In recognition of his research accomplishments at Yale, Dr. Breaker received the Arthur Greer Memorial Prize (1997), the Eli Lilly Award in Microbiology (2005), the Molecular Biology Award from the U.S. National Academy of Sciences (2006), and the Merck Award from the American Society for Biochemistry and Molecular Biology (2016). Dr. Breaker was inducted into the U.S. National Academy of Sciences in 2014. He has cofounded two biotechnology companies and is a scientific advisor for industry and for various government agencies. He serves on the editorial board for the scientific journals RNA Biology, RNA, and Cell Chemical Biology.
    • Harvey and Kate Cushing Professor of Cell Biology, Professor of Biomedical Engineering, and Professor of Physics; Vice Chair for Diversity, Equity and Inclusion, Cell Biology

      Joerg Bewersdorf is the Harvey and Kate Cushing Professor of Cell Biology and Professor of Biomedical Engineering and of Physics at Yale University. He received his Master's degree (Dipl. Phys., 1998) and his doctoral degree in physics (Dr. rer. nat., 2002) from the University of Heidelberg training with Dr. Stefan W. Hell at the Max Planck Institute for Biophysical Chemistry in Goettingen, Germany. Since 2009, after 4 years at The Jackson Laboratory in Bar Harbor, Maine, he has been leading a research group at Yale University focusing on the development of new light microscopy techniques and their application to biomedical research. An optical physicist/biophysicist by training, Dr. Bewersdorf has been a long-time contributor to the field of super-resolution light microscopy development and the application of these techniques to cell biological questions.
    • John C. Malone Professor of Molecular, Cellular, and Developmental Biology and Professor of Chemistry, of Pharmacology, and of Management; Executive Director, Yale Center for Molecular Discovery

      Dr. Crews is the John C. Malone Professor of Molecular, Cellular and Developmental Biology and holds joint appointments in the departments of Chemistry and Pharmacology at Yale University. He graduated from the U.Virginia with a B.A. in Chemistry and received his Ph.D. from Harvard University in Biochemistry. Dr. Crews has a foothold in both the academic and biotech arenas; on the faculty at Yale since 1995, his laboratory has pioneered the use of small molecules to control intracellular protein levels. In 2003, he co-founded Proteolix, Inc., whose proteasome inhibitor, Kyprolis™ received FDA approval for the treatment of multiple myeloma. Since Proteolix’s purchase by Onyx Pharmaceuticals in 2009, Dr. Crews has focused on a new drug development technology, which served as the founding intellectual property for his latest New Haven-based biotech venture, Arvinas, Inc. Currently, Dr. Crews serves on several editorial boards and was Editor of Cell Chemical Biology (2008-2018). In addition, he has received numerous awards and honors, including the 2013 CURE Entrepreneur of the Year Award, 2014 Ehrlich Award for Medicinal Chemistry, 2015 Yale Cancer Center Translational Research Prize, a NIH R35 Outstanding Investigator Award (2015), the AACR Award for Chemistry in Cancer Research (2017), Khorana Prize from the Royal Society of Chemistry (2018), Pierre Fabre Award for Therapeutic Innovation (2018), the Pharmacia-ASPET Award for Experimental Therapeutics (2019), the Heinrich Wieland Prize (2020) and the Scheele Prize (2021). In 2019, he was named an American Cancer Society Professor and received the Connecticut Medal of Technology in 2022 as well as the Gabbay Award for Biotechnology and Medicine in 2023.
    • Professor of Neurosurgery and of Neuroscience; Co Vice Chair of Research, Neurosurgery; Director, Interdepartmental Neuroscience Graduate Program

      Dr. Charles A. Greer is the Vice Chair for Research and holds the rank of Professor of Neuroscience. Dr. Greer also serves as Director of the Yale Interdepartmental Neuroscience Graduate Program. He has served as the President of the Association for Chemoreception Sciences, Chair of National Institutes of Health Study Sections and recently completed a term on the Advisory Council for the National Institute of Deafness and Other Communicative Disorders. He has organized several national and international conferences and is frequently an invited speaker. Dr. Greer is an Associate Editor of The Journal of Comparative Neurology and Journal of Neuroscience and a member of the editorial boards of Frontiers in Neurogenomics, Frontiers in Neuroanatomy and Frontiers in Neuorgenesis and the Faculty of 1000. Dr. Greer has been the recipient of numerous awards recognizing his research accomplishments.
    • Professor of Microbial Pathogenesis

      Dr. Liu has been working in the field of electron microscopy for 20 years. In particular, he gained expertise in cryo-electron tomography (cryo-ET) after working with Prof. Ken Taylor at Florida State University and Dr. Sriram Subramaniam at NIH. Since he started his own laboratory in 2007, he has been dedicated to developing high-throughput cryo-ET pipeline in which both data collection and image analysis are streamlined and automated. The high-throughput cryo-ET pipeline is becoming increasingly powerful, enabling his laboratory to visualize over 100,000 cells from 100 different bacterial species. More importantly, the massive data from cryo-ET has been systematically utilized to gain structural insights into fundamental biological processes related to signaling transduction, flagellar assembly, protein secretion, phage adsorption DNA translocation, and host-pathogen interactions. Dr. Liu has published more than 60 papers in journals that include Nature, Science, PNAS, and Cell.
    • Joseph S. and Sophia S. Fruton Professor of Astronomy and Professor of Physics; Chair of Women Faculty Forum

      She is a theoretical astrophysicist interested in cosmology, gravitational lensing and black hole physics. Her research involves mapping the detailed distribution of dark matter in the universe exploiting the bending of light en-route to us from distant galaxies. In particular, she has focused on making dark matter maps of clusters of galaxies, the largest known repositories of dark matter. Gravitational lensing by clusters can also be utilized to constrain dark energy models and she has been developing the methodology and techniques to do so. Her work has demonstrated that cluster strong lensing offers a unique and potentially powerful laboratory to test evolving dark energy models.Priya is also actively engaged in deriving and understanding the mass assembly history of black holes over cosmic time. She is exploring a new channel for the formation of the first black holes and its observational consequences at high and low redshift. This channel produces massive seeds derived from the direct collapse of pre-galactic gas disks at the earliest epochs. This is in contrast to the conventional picture wherein light seeds are produced from the end state of the first stars. Current measurements of the masses of black holes hosted in nearby faint galaxies supports the existence of a massive seeding model. In earlier work, she argued for the existence of an upper limit to black hole masses in the universe by showing that black holes eventually stunt their own growth. This self-regulation implies the presence of ultra-massive black holes with capped masses in the centers of nearby galaxies that have since been observationally detected.In addition to her academic position at Yale, she also currently holds the Sophie and Tycho Brahe Professorship of the Dark Cosmology Center, Niels Bohr Institute, at the University of Copenhagen, Denmark. She has been recently elected to an Honorary Professorship for life at the University of Delhi, India.
    • R. Selden Rose Professor of Molecular Biophysics and Biochemistry and Professor of Cell Biology; Director, Yale Center for RNA Science and Medicine

      Karla Neugebauer holds a BS in Biology from Cornell University and a PhD in Neuroscience from UCSF. She switched gears to RNA biology as a postdoc with Mark Roth at Fred Hutchinson Cancer Research Center. There she participated in the initial description of the SR protein family of splicing regulators and was inspired to study RNA metabolism in vivo by combining imaging, genomics, and sequencing strategies. From 2001-2013 she was a Research Group Leader at the Max Planck Institute of Cell biology and Genetics in Dresden Germany. In 2013, she moved to Yale as a Professor of Molecular Biophysics and Biochemistry and of Cell Biology. She has been the Director of the Yale Center for RNA Science and Biomedicine since 2018 and was recognized internationally for her work in RNA Biology by the RNA Society (2017 mid-career award). She has studied splicing in relation to nuclear speckles and discovered that most introns are removed during the process, or co-transcriptionally. Her lab has shown that snRNP assembly occurs in membraneless organelles called Cajal bodies (CBs) and that depletion of the CB scaffolding protein coilin is lethal in zebrafish embryos, due to a deficit in splicing. She is passionate about climate change, believing that everyone has something to contribute to meet its challenges. She is currently developing biochemistry curriculum to show the relevance of the discipline to meeting the current and future needs of our planet.
    • Harvey and Kate Cushing Professor of Genetics; Chair, Genetics

      Valerie Reinke attended University of Illinois, receiving her B.S. in Genetics in 1990. She then went to University of Texas Health Sciences Center in Houston, Texas for graduate work in the laboratory of Gigi Lozano. There she studied mechanisms of tumor suppression by the factor p53, and received her PhD in Biomedical Sciences in 1996. Valerie performed her postdoctoral work in the laboratory of Stuart Kim at Stanford University in California, focusing on initiating genomic studies of a model organism, the nematode C. elegans. While there, she developed an interest in the role of gene expression in regulating C. elegans germline development. In 2000, she joined the faculty of the Department of Genetics at Yale School of Medicine, and continues to apply genome-wide technologies to understanding gene regulatory mechanisms in the germ line.
    • Anthony N. Brady Professor of Comparative Medicine and of Pathology; Deputy Chair, Comparative Medicine

      Yajaira studied Biochemistry and Molecular Biology at the University Autonoma of Madrid (1995). She did her PhD with Miguel Angel Lasuncion at the Hospital Ramón y Cajal and the University Autonoma de Madrid (Spain) (1996-2001). Yajaira also did two post-docs. The first one with Alberto Muñoz at the Instituto de Investigaciones Biomédicas "Alberto Sols" and the Consejo Superior de Investigaciones Científicas-Universidad Autonoma de Madrid (Spain) (2002-2005) and the second one with Jordan Pober and Bill Sessa at Yale University School of Medicine (2005-2009). Yajaira initiated her independent research career in the Division of Cardiology at New York University School of Medicine in 2009. She joined the Yale faculty in 2013 as an Assistant Professor of Comparative Medicine and Pathology. Yajaira is currently Anthony N. Brady Professor of Comparative Medicine and also serves as Deputy Chair for the Department of Comparative Medicine.
    • Professor of Chemistry; Admission Committee Chair, Chemistry; Editorial Board Members, Biophysical Journal; Scientific Advisory Board Members, Polymer Research; Review Panelist, Molecular Architecture of Life

      Elsa Yan was born and grew up in Hong Kong. She graduated from the Chinese University of Hong Kong in 1995. Working with Kenneth Eisenthal on nonlinear optics and surface sciences, she obtained her Ph.D. at Columbia University in 2000. From 2000-2004, she was a postdoctoral fellow in Richard Mathies's lab at UC Berkeley and a visiting fellow in Thomas Sakmar's lab at the Rockefeller University. She combined Raman spectroscopy with techniques in molecular biology to understand the molecular mechanism of signal transduction in the G-protein coupled receptor rhodopsin. In 2004, she joined The Rockefeller University, where she continued to develop methods in expression and purification of membrane proteins. In 2007, Elsa became an Assistant Professor of Chemistry at Yale. She was promoted to Associate Professor in 2012 and Full Professor in 2014.
  • Term (Clinical) Appointments & Promotions Committee

    • Committee Chair

      Harold W. Jockers Professor of Medicine, Deputy Dean for Academic Affairs

      Dr. Linda Bockenstedt is the Harold W. Jockers Professor of Medicine, Section of Rheumatology, and Deputy Dean for Faculty Affairs at Yale School of Medicine. She received her undergraduate degree in chemistry and physics from Harvard College and is a graduate of the Ohio State University School of Medicine. After completing residency training in medicine and serving as Chief Resident in Medicine at Yale, Dr. Bockenstedt obtained rheumatology clinical and research fellowship training at the University of California, San Francisco. She has been a faculty member at Yale School of Medicine since 1989, where she directs a research program devoted toward understanding the pathogenesis of Lyme disease, an infection-related rheumatic disease. Her research has been continually supported by the National Institutes of Health since 1990, and she is internationally recognized for her studies of the host immune response to spirochetal infection. As a physician-scientist, she also is an active clinician and educator for medical trainees. Dr. Bockenstedt is a Master of the American College of Rheumatology, and an elected member of the Kunkel Society and the Interurban Clinical Club. She is a former standing member of the Immunity and Host Defense Study Section at NIH and former member of the Board of Directors for the American College of Rheumatology Research & Education Foundation. She currently serves on the NIH NIAID Council and the DOD Tick-Borne Disease Research Program Programmatic Panel. Since 2006 she has been active in faculty affairs at Yale School of Medicine and in 2017, was appointed YSM Deputy Dean for Academic Affairs.
    • Term January 2022-December 2024

      Professor of Ophthalmology & Visual Science; Chief, Yale New Haven Health/Bridgeport Hospital; Vice Chairman of Faculty Affairs, Ophthalmology; Affiliated Faculty, Yale Institute for Global Health

      Dr. Brian DeBroff specializes in cataract and IOL implantation surgery. He has particular clinical and research interests in Femtosecond Laser Assisted Cataract Surgery, Optiwave Refractive Analysis using intraoperative wave front analysis for optimizing refractive results with implant surgery, multifocal and EDOF IOL’s after cataract surgery. He is a preceptor to train other Ophthalmologists in the Catalys Precision Laser Cataract System. He was appointed Director of cataract and IOL implant surgery at the Department of Ophthalmology and Visual Science at the Yale School of Medicine in 1999. Dr. DeBroff graduated from the Tufts University School of Medicine where he was inducted in the Sir William Osler and Alpha Omega Alpha Honor Societies. He is Vice Chairman of Yale Ophthalmology, Director of Faculty Affairs, and serves on the Board of Permanent Officers at Yale University. He has held positions at Yale including Chief of Ophthalmology, VA Connecticut, Chief of Ophthalmology Yale New Haven Health/Bridgeport, and Residency Program Director. He was presented with the Yale Resident Teaching Award in 1998 and 2008. Dr. DeBroff has over 100 publications including a book on phacoemulsification cataract surgery, and he has written seven book chapters and has lectured nationally and internationally. He is Editor-in-Chief of Advances in Ophth & Visual Sys and is on the editorial board/Senior Reviewer for the Journal of Cataract and Refractive Surgery, Archives of Ophthalmology, and British Journal of Ophthalmology and Dr. DeBroff was inducted in the IIIC (International Intra-Ocular Implant Society) founded by Sir Harold Ridley and has received awards by Best Doctors, Castle Connolly, Connecticut Magazine, and New York Magazine. He was recently inducted in: Best Cataract Surgeons in America.
    • Term January 2024-December 2026

      Professor of Pediatrics (General Medicine); Interim Section Chief, General Pediatrics; Medical Director of Pediatric Primary Care; Vice Chair for Faculty Affairs and Professional Development, Pediatrics

      Dr. Flaherty-Hewitt is a native New Yorker. She completed her undergraduate studies in Chemistry/Pre-Medicine at the College of the Holy Cross in Worcester, MA. She received her MD from SUNY Downstate in Brooklyn. She completed her residency in Pediatrics at New York Presbyterian Hospital- Weill Cornell Medical School and also served a year as Chief Resident. She came to New Haven in 2002 working both at St. Raphael's and Yale New Haven Hospitals. She loves being a Pediatrician and values the relationships she has developed with families. She also values her role as an educator to new physicians. She lives in Hamden with her husband and 2 children.
    • Term January 2024-December 2026

      Professor of Surgery (Otolaryngology)

      John F. Kveton M.D. is an internationally recognized neurotologist who has practiced in Connecticut since 1989 when he joined the Section of Otolaryngology at Yale University School of Medicine.  Dr. Kveton received his M.D. degree from St. Louis University School of Medicine in 1978.  He completed his surgical internship and otolaryngology residency at Yale New Haven Medical Center before working as a neurotology fellow at the EAR Foundation with Michael Glasscock, M.D. in 1982-1983.  As a faculty member at St. Louis University School of Medicine, Dr. Kveton performed the first cochlear implant in St. Louis in 1984.   He founded the cochlear implant program at the Lahey Clinic in Burlington, Massachusetts and developed the first skull base surgical team there.  Dr. Kveton returned to Yale in 1989 and remained on as a full-time faculty member under the title of Professor of Surgery/Otolaryngology and Professor of Neurosurgery until 2002.   During that time he pioneered the use of hydroxyapatite cement in skull base surgery.   Dr. Kveton has remained active on the clinical faculty of the Division of Otolaryngology at Yale as a partner in Ear Nose & Throat Medical and Surgical Group in the New Haven. He has since returned as the Director of Otology and Neurotology in the Division of Otolaryngology.Dr. Kveton has published over 100 original articles, reviews book chapters and serves as an editorial reviewer for several medical journals, including the New England Journal of Medicine, Laryngoscope and Otology & Neurotology.  Dr. Kveton is a frequent national lecturer.  He has served as a Senior Examiner for the American Board of Otolaryngology and was a founding examiner for the Neurotology Sub-Certification Board.  Dr. Kveton has served as President of the CT ENT Society and New England Otolaryngological Society as well as numerous professional committees.  Dr. Kveton has been recognized in the Best Doctors in the U.S. and Best Doctors in the New York Metro Region since 1997.
    • Term January 2024-December 2026

      Professor of Psychiatry; Chair, Bridgeport Hospital, Department of Psychiatry

      YCCI K ScholarProject: 09/30/06 - 06/30/09Sleep and cognition in cocaine dependece
    • Term January 2022-December 2025

      Professor of Medicine (Cardiovascular Medicine); Cardiology Section Chief, VA Connecticut, VA Connecticut Healthcare System

    • Term January 2023-December 2025

      Professor of Medicine (Cardiovascular Medicine)

      Mark H. Schoenfeld, MD, FACC ,FAHA, FHRS has been a Clinical Professor of Medicine at the Yale University School of Medicine for nearly 2 decades as well as a Fellow of Saybrook College, Yale University, and Professor in the Dept of Cardiovascular Medicine at Frank H. Netter MD School of Medicine, Quinnipiac University. After graduating from Yale College and Harvard Medical School he was a medical resident, cardiac fellow and one of the earliest fellows in cardiac electrophysiology and pacing at the Massachusetts General Hospital before returning to Yale. He established the Cardiac Electrophysiology and Pacing Laboratories at both the Hospital of St Raphael (New Haven) and St Mary's Hospital (Waterbury). He has been involved in numerous clinical trials, having been one of the original investigators of the implantable cardioverter-defibrillator and multiple elaborations of this technology thereafter including transvenous devices and cardiac resynchronization therapy and his involvement with catheter ablation for the management of cardiac arrhythmias extends back more than 3 decades. He served as President of the Heart Rhythm Society (HRS), the international organization dedicated to improving the care of patients with cardiac arrhythmias by promoting research, education and optimal health care policies and standards, and has served as the Governor of the Connecticut Chapter of the American College of Cardiology (ACC). Beyond caring for thousands of patients, being involved in clinical research and  in teaching, he has helped to develop ACC/AHA/HRS  medical guidelines to guide practitioners on the management of patients with cardiac arrhythmias. He has been active in health care policy and regulatory affairs as relates to cardiology and cardiac electrophysiology, working with the FDA on drug/device approval and the Centers for Medicare and Medicaid Services (CMS) by serving on the Relative Value Scale Update Committee (RUC) of the American Medical Association which advises CMS on reimbursement.
    • Term January 2023-December 2025

      Professor of Medicine (Medical Oncology)

      Dr. Silber is the Associate CEHE Director for Clinical Research. As a medical oncologist who serves as the Medical Director and Physician Champion of the Centers for Disease Control/Connecticut Department of Public Health's 5-year provider supported grant at Yale New Haven Hospital entitled, The Connecticut Cancer Screening Program (CCSP), she designed the Comprehensive Breast Cancer Outreach and Support Program for Underserved Women, which is a culturally competent program supported by the Breast Cancer Alliance of Greenwich. She has supervised Community Health Educators dating back to 1996, when she received a national Komen award for the Sister to Sister Program, and has been recognized for expertise in breast cancer among African American women. She has directed a cancer clinic for the uninsured and underinsured for two decades and have formed community relationships, which require many years to nurture and demonstrate constancy. This year, she became the principal investigator of the Avon-Pfizer Metastatic Breast Cancer Grants Program: Identify-Amplify-Unify. This program assists organizations that provide information and services to help patients in navigating the medical and emotional challenges associated with their disease. Dr. Silber was awarded this grant from a highly competitive pool of 23 non-profit organizations nationally. Also, this year, CT Health and Educational Facilities Authority (CHEFA) awarded a grant to fund a novel program called “Breast Cancer S.W.A.T. Team- We’ve got your back!”. Learn more about Dr. Silber>>As a principal investigator, she assists economically disadvantaged breast cancer patients to adhere to treatment using medical legal partnership. This year, she was selected to participate as a leadership fellow of the Connecticut Health Foundation. The fellowship was established in 2005, and brings together diverse individuals from multiple sectors who are dedicated to achieving health equity. Each year, the foundation selects up to 20 participants into this competitive ten-month program. Throughout this program, her project has been to increase clinical trial participation among ethnic minorities and capitalize on opportunities created by the Affordable Care Act.  On May 1, 2015, she was named Assistant Clinical Director for Diversity and Health Equity at Yale Cancer Center and focuses on engagement with community partners in improving education for prevention and screening and access to cancer care for diverse populations within the local community as well as Greater New Haven area.
    • Term January 2022-December 2024

      Professor of Medicine

      Dr. Wu directs the first and last course at Yale School of Medicine, the Introduction to the Profession and Capstone course, respectively. He also recruits and trains 200 faculty involved in the clinical skills training and interprofessional education for medical, nurse practitioner and physician associate students. He co-directs the Connecticut Older Adult Collaboration for Health (COACH) 4M to enhance the geriatric workforce in primary care and is Chair of the Health Committee for the Yale China Association and collaborated on a model of residency training at Xingaya Hospitals adopted by the government of China.
  • Term Appointments & Promotions Committee

    • Committee Chair

      Harold W. Jockers Professor of Medicine, Deputy Dean for Academic Affairs

      Dr. Linda Bockenstedt is the Harold W. Jockers Professor of Medicine, Section of Rheumatology, and Deputy Dean for Faculty Affairs at Yale School of Medicine. She received her undergraduate degree in chemistry and physics from Harvard College and is a graduate of the Ohio State University School of Medicine. After completing residency training in medicine and serving as Chief Resident in Medicine at Yale, Dr. Bockenstedt obtained rheumatology clinical and research fellowship training at the University of California, San Francisco. She has been a faculty member at Yale School of Medicine since 1989, where she directs a research program devoted toward understanding the pathogenesis of Lyme disease, an infection-related rheumatic disease. Her research has been continually supported by the National Institutes of Health since 1990, and she is internationally recognized for her studies of the host immune response to spirochetal infection. As a physician-scientist, she also is an active clinician and educator for medical trainees. Dr. Bockenstedt is a Master of the American College of Rheumatology, and an elected member of the Kunkel Society and the Interurban Clinical Club. She is a former standing member of the Immunity and Host Defense Study Section at NIH and former member of the Board of Directors for the American College of Rheumatology Research & Education Foundation. She currently serves on the NIH NIAID Council and the DOD Tick-Borne Disease Research Program Programmatic Panel. Since 2006 she has been active in faculty affairs at Yale School of Medicine and in 2017, was appointed YSM Deputy Dean for Academic Affairs.
    • Term January 2022-December 2024

      Professor of Pediatrics (Emergency Medicine) and of Emergency Medicine; Executive Team Member, Co-lead Knowledge Management, Emergency Medical Services for Children Innovation and Improvement Center; Director, Pediatric Simulation, Yale Center for Healthcare Simulation, Yale Center for Healthcare Simulation; Co-director of Education, Yale Site Lead, Pediatric Pandemic Network

      Marc is a Professor of Pediatrics and Emergency Medicine at Yale. He is the Director of Pediatric Simulation at the Yale Center for Medical Simulation and was the founding co-chair of INSPIRE, the world’s largest simulation-based research network. His academic work focuses on the use of innovative techniques and technologies, such as simulation, to measure and improve the quality of pediatric emergency care. His overarching goal is to ensure that all children, no matter where they live, go to school or travel, receive the highest quality emergency medical care. Marc serves in a national role with HRSA/EMSC on the EIIC executive committee and co-leading the EIIC Knowledge Management as well as serving as the education co-lead of the Pediatric Pandemic Network. Prior to these roles he served as the CT EMSC State Partnership Grant Medical Director for seven years and as an investigator on four different EMSC targeted issues grants and the leader on the EIIC Prehospital Emergency Care Collaborative. His projects involve working closely with prehospital and hospital emergency care coordinators leading pediatric efforts in community EDs and community EMS agencies. In addition Marc is actively working on multiple initiatives through other organizations (including SAEM, Pediatric Trauma Societies, American Heart Association, Emergency Nurses Association, American Academy of Pediatrics, NASEMSO). Marc serves as the PI of the ImPACTS study, a national effort to describe, measure and improve the quality of care provided to critically ill and injured pediatric patients in emergency departments using simulation. Marc completed a K30 Masters of Science in Clinical Investigation with a focus in translational medicine at New York University and post-graduate course work on simulation at Harvard’s Center for Medical Simulation. He has substantial leadership experiences in trauma and simulation research as a board member of the International Pediatric Simulation Society, co-chair of the Pediatric Academic Society’s Special Interest Group on Simulation-Based Research and as a leader on the Pediatric Trauma Society’s Guideline Committee. He has served as the principal investigator on multiple funded trauma and simulation research projects to ensure the optimal care for ill and injured children. This includes a grant-funded project using simulation training for disaster preparedness, a regional trauma simulation program, a local office based preparedness program.
    • Term January 2022-December 2024

      Professor of Medicine (General Medicine); Section Chief of General Internal Medicine VA Connecticut Healthcare System, Internal Medicine; Director, Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center, Research

      I began my 31 year research career at Duke University and the Durham VA in 1991 and moved to VA Connecticut and University of Connecticut in 2012. In January 2016, I was appointed Section Chief of Chief of General Internal Medicine at VA Connecticut in West Haven and Professor of Medicine at Yale. In this role, I oversee the academic development and clinical productivity of the hospitalists, primary care, and research faculty based at VA Connecticut. I also serve as the Director and Principal Investigator of the Pain Research, Informatics, Multimorbidities, and Education (PRIME) Center of Excellence at VA Connecticut. This is a  VA HSR&D center grant providing over 7 million in infrastructure support for multidisciplinary research focusing on improving pain in Veterans.
    • Term January 2024-December 2026

      Professor of Therapeutic Radiology; Director of Physics Research, Therapeutic Radiology; Associate Director of Medical Physics Residency Program, Therapeutic Radiology

      Dr. Jun Deng is a Professor at the Department of Therapeutic Radiology of Yale University School of Medicine and an ABR board certified medical physicist at Yale-New Haven Hospital. Dr. Deng obtained his PhD from University of Virginia in 1998 and finished his postdoctoral fellowship at Stanford University in 2001. Currently with funding from NIBIB, NSF, NCI, DOE and YCC, Dr. Deng’s research has been focused on artificial intelligence, machine learning, big data, and medical imaging for early cancer detection, real-time clinical decision support, digital twins of cancer patients, as well as AI-empowered mobile health and smart medicine. Dr. Deng has been serving on the Editorial Board of numerous peer-reviewed journals, on the study sections of NIH, NSF, DOD, ACS, RSNA and ASTRO since 2005, and as scientific reviewer for various science foundations and institutions since 2015. Dr. Deng is an elected fellow of Institute of Physics, AAPM, and ASTRO.
    • Term January 2024-December 2026

      Professor of Ophthalmology and Visual Science

      Jonathan Demb is a Professor in the Department of Ophthalmology & Visual Science with secondary appointments in the Department of Cellular & Molecular Physiology and the Department of Neuroscience. Dr. Demb obtained his doctoral degree from Stanford University and did postdoctoral training at the University of Pennsylvania. Demb was a faculty member at the University of Michigan before moving to Yale in 2011. The Demb lab investigates the cellular and synaptic mechanisms that enable visual processing by the mammalian retina. Major accomplishments include identifying fundamental nonlinearities at retinal synapses that mediate specialized spatial processing by retinal ganglion cells; elucidating the role of disinhibition in visual contrast processing; characterizing asymmetries between the retina's ON and OFF pathways; determining roles of NMDA-type glutamate receptors in ganglion cell receptive fields; identifying characteristic properties of cone-mediated vision in the mouse retina; developing the use of a glutamate sensor (iGluSnFR) for study of retinal circuitry; identifying novel amacrine cell circuits using optogenetic technology; and testing experimental therapies in mouse models of retinal disease. Demb is a Reviewing Editor at the Journal of Neuroscience and is on the Editorial Board of PLoS Biology. He was awarded the Cogan Award in 2013 from the Associate for Research in Vision and Ophthalmology (ARVO) to recognize his contributions to the field of retinal neuroscience.
    • Term January 2023-December 2025

      Charles W. Ohse Professor of Surgery (Otolaryngology), Vice Chair, Faculty Affairs; Chief, Division of Otolaryngology, Yale Medicine; Vice Chair of Faculty Affairs, Surgery

      Dr. Judson is a head and neck surgeon, investigator, and educator, who is passionate about the mission of academic medicine. He previously served as Chief Ambulatory Officer of Smilow Cancer Hospital and Program Director of the Yale Otolaryngology Residency. His surgical practice focuses on the treatment of benign and malignant tumors and other surgical disorders of the head and neck. He was an early adopter of trans oral robotic surgery and specializes in minimally invasive surgical approaches including endoscopic laser and tailored open surgeries. He routinely operates on complex and difficult cases and works with a multidisciplinary team of other surgeons, medical oncologists, radiation doctors, and other specialist providers. As an investigator, Dr. Judson started a tumor biorepository that supports multiple laboratory investigations of head and neck cancer at Yale and other institutions. His recent investigation has been on the role of bile acid reflux in hypopharyngeal carcinogenesis and identifying saliva biomarkers of oral potentially malignant disorders and cancers. He was an early adaptor of using large national databases to study uncommon head and neck tumors. He is Associate Editor of the journal Head & Neck. Dr. Judson attended Middlebury College, obtained a master’s degree at the University of Pennsylvania, and graduated from Jefferson Medical College. He completed a residency at Georgetown University Hospital in Otolaryngology – Head and Neck Surgery, and a fellowship at Memorial Sloan-Kettering Cancer Center in Head and Neck Surgical Oncology. Before working in medicine, he was a Peace Corp Volunteer in Sri Lanka and worked as Assistant Deputy Mayor of the City of Philadelphia. He completed a Master of Business Administration degree at the Yale School of Management in 2022.
    • Term January 2023-December 2025

      Professor of Psychiatry; Director, The Consultation Center, Psychiatry; Director, YaleEval, Psychiatry

      Joy S. Kaufman, PhD is a Professor of Psychiatry (Psychology Section), Yale School of Medicine and Executive Director of the Yale Consultation Center and of YaleEVAL. Trained as a Clinical and Community Psychologist, Dr. Kaufman conducts large-scale, multi-level evaluations of health service delivery systems, provides consultation to governmental and community organizations regarding these evaluations, and carries out related research. These evaluations take place in under-resourced communities; involve close partnerships with state and municipal governments, community organizations, and other public stakeholders; and generate data that informs program and policy development. A unique feature of her work is the training of public stakeholders to evaluate the services they receive or to utilize data so that they can provide rigorous and systematic feedback to improve services and participate in decision-making about their community. Dr. Kaufman's research interests include the identification of contextual factors that impact outcomes for individuals with emotional and behavioral difficulties.
    • Term January 2022-December 2024

      Professor of Medicine; Director, Clinical Hepatology, Digestive Diseases; Vice-Chief of Hepatology, Section of Digestive Diseases, Digestive Diseases; Director, Yale Viral Hepatitis Program

    • Term January 2022-December 2024

      Professor of Pathology; Director, Renal Pathology and Electron Microscopy Laboratory, Pathology; Director, Renal & Genitourinary Fellowship Program, Pathology

      Dr. Moeckel graduated magna cum laude from Ludwig Maximillians University in Munich, Germany. He trained in anatomic and clinical pathology at the University of Arizona, Tucson, AZ and was on faculty in the Department of Pathology at Vanderbilt University, Nashville, TN prior to his recruitment as Director of the Renal Pathology and Electron Microscopy Laboratory at Yale University. His academic interests are in clinical renal pathology and research of mechanisms of kidney injury repair and progression of chronic kidney disease. Dr Moeckel is a fellow of the American Society of Nephrology and a Diplomat of the American Board of Pathology. He has published numerous papers in peer reviewed journals and has received private industry and federal grants to support his research.
    • Term September 2023-Septmenber 2026

      Professor of Pediatrics (Hematology/Oncology); Fellowship Director, Pediatric Hematology & Oncology Program; Director, Solid Tumor Program, Pediatric Hematology & Oncology Program; Children's Oncology Group Site PI, Pediatric Hematology & Oncology Program

      Dr Farzana Pashankar is an accomplished pediatric hematologist oncologist, specializing in care of children with sickle cell disease and solid tumors. She is an international expert in germ cell tumors and rare tumors. Her research has focused on clinical trial development through Children's Oncology Group, and she is the Chair and Vice Chair of international trials in germ cell tumors. Dr Pashankar is Director of Pediatric Solid Tumor Program, Disease Aligned Research Team Leader for Pediatrics at Smilow Cancer Center and Director of the Pediatric Hematology Oncology Fellowship Program. Dr Pashankar received her MBBS and MD from University of Pune, India. She trained in United Kingdom, receiving an MRCP. She subsequently did a residency at University of Iowa and fellowship at British Columbia Children's Hospital, before joining Yale in 2005.
    • Term January 2022-December 2024

      Professor of Anesthesiology; Director, Thoracic and Vascular Anesthesia Division

      Wanda M. Popescu M.D. is the Director of the Thoracic and Vascular Anesthesia Section in the Department of Anesthesiology, Yale School of Medicine, New Haven, Connecticut. Dr. Popescu received her medical degree from Carol Davila Medical School, University of Medicine and Pharmacy, Bucharest, Romania in 1996. She completed her anesthesiology residency training at Yale New Haven Hospital in New Haven, USA in 2002. She undertook two fellowships in vascular and cardio-thoracic anesthesiology at Yale School of Medicine between 2002 and 2004. Subsequently, she remained on faculty and currently serves as a Professor of Anesthesiology at Yale School of Medicine and is the Director of the Thoracic and Vascular Anesthesia Section. Dr. Popescu is an active member of many professional societies, including the Society of Cardiovascular Anesthesiologists and the American Society of Anesthesiologists. She is the Chair of the Advanced Perioperative Transesophageal Echocardiography Examination writing committee for the National Board of Echocardiography and a member of its Board of Directors. She is also a senior Part 2 board examiner for the American Board of Anesthesiology. Dr. Popescu is one of the two editors of “Master Techniques in Upper and Lower Airway Management”, a print and e-book, which includes over 120 videos. Dr. Popescu has been a member of several national and international guideline writing committees, having co-authored Guidelines for enhanced recovery after lung surgery. She has lectured at multiple national and international meetings.
    • Term January 2022-December 2024

      Professor of Medicine (General Medicine) and of Epidemiology of Microbial Diseases

      Dr. Andre Sofair is a Professor in the Department of Internal Medicine at the Yale Medical School and holds a secondary appointment in the School of Public Health’s Department of Epidemiology of Microbial Diseases. He went to medical school at the Albert Einstein College of Medicine (1986) and completed his Master’s in Public Health at the Yale School of Public Health in 1997. He is an attending physician and Firm Chief at Yale New-Haven Hospital. He is also a lead organizer for the medical chief residency program at the University of Rwanda. In addition to leading many studies in hepatitis and clinical care, he has lectured widely on biomedical ethics and eugenic sterilization.  He serves as co-director of the viral hepatitis clinic at the St. Raphael Campus.